New York State Common Retirement Fund
STLN

New York State Common Retirement Fund’s Starling Oncology STLN Stock Holding History

New York State Common Retirement Fund’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.2K Buy
17,900
+12,300
+220% +$51.7K ﹤0.01% 2709
2026
Q1 		$17.2K Hold
5,600
– – ﹤0.01% 3030
2025
Q4 		$19.9K Hold
5,600
– – ﹤0.01% 3089
2025
Q3 		$19.5K Sell
5,600
-39,100
-87% -$134K ﹤0.01% 3111
2025
Q2 		$91.6K Buy
+44,700
New +$112K ﹤0.01% 2739
2023
Q3 		– Sell
-309
Closed -$170 – 3369
2023
Q2 		$170 Sell
309
-10,800
-97% -$5.71K ﹤0.01% 3405
2023
Q1 		$7.53K Hold
11,109
– – ﹤0.01% 3188
2022
Q4 		$18.3K Buy
11,109
+135
+1% +$379 ﹤0.01% 3189
2022
Q3 		$51K Sell
10,974
-4,826
-31% -$28.4K ﹤0.01% 3136
2022
Q2 		$80K Buy
+15,800
New +$115K ﹤0.01% 3149

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

New York State Common Retirement Fund's STLN Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Starling Oncology (STLN) stake by 220% in Q2 2026, buying an estimated $51.7K and bringing the position to 17,900 shares worth $97.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

New York State Common Retirement Fund first reported a position in STLN in Q2 2022 and has held it in 10 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • New York State Common Retirement Fund held 17,900 shares of Starling Oncology worth $97.2K as of Q2 2026.
  • New York State Common Retirement Fund bought 12,300 Starling Oncology shares in Q2 2026, an estimated $51.7K.
  • Starling Oncology made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2709 holding.
  • New York State Common Retirement Fund first reported a position in Starling Oncology in Q2 2022 and has held it in 10 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.